These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36591853)

  • 41. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
    Mariño Z; Darnell A; Lens S; Sapena V; Díaz A; Belmonte E; Perelló C; Calleja JL; Varela M; Rodriguez M; Rodriguez de Lope C; Llerena S; Torras X; Gallego A; Sala M; Morillas RM; Minguez B; Llaneras J; Coll S; Carrion JA; Iñarrairaegui M; Sangro B; Vilana R; Sole M; Ayuso C; Ríos J; Forns X; Bruix J; Reig M
    J Hepatol; 2019 May; 70(5):874-884. PubMed ID: 30684506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.
    Hsu CS; Lang HC; Huang KY; Chao YC; Chen CL
    Hepatol Int; 2018 Nov; 12(6):531-543. PubMed ID: 30426396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
    JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
    Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
    Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
    Gutin L; Yao F; Dodge JL; Grab J; Mehta N
    JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
    Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
    Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
    World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Roudot-Thoraval F; Audureau E;
    Gastroenterology; 2018 Nov; 155(5):1436-1450.e6. PubMed ID: 30031138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
    Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
    World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
    Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
    Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.
    Shim JJ; Oh CH; Kim JW; Lee CK; Kim BH
    Scand J Gastroenterol; 2017 Sep; 52(9):1029-1036. PubMed ID: 28562104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease.
    Kawamura Y; Arase Y; Ikeda K; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Inao M; Mochida S; Kumada H
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):597-605. PubMed ID: 26707683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    Ripoll C; Groszmann RJ; Garcia-Tsao G; Bosch J; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS;
    J Hepatol; 2009 May; 50(5):923-8. PubMed ID: 19303163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project.
    McGlynn KA; Sahasrabuddhe VV; Campbell PT; Graubard BI; Chen J; Schwartz LM; Petrick JL; Alavanja MC; Andreotti G; Boggs DA; Buring JE; Chan AT; Freedman ND; Gapstur SM; Hollenbeck AR; Hou L; King LY; Koshiol J; Linet M; Palmer JR; Poynter JN; Purdue M; Robien K; Schairer C; Sesso HD; Sigurdson A; Wactawski-Wende J; Zeleniuch-Jacquotte A
    Br J Cancer; 2015 Mar; 112(7):1266-72. PubMed ID: 25742475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
    Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.
    Tachi Y; Kozuka A; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    Nutrition; 2018 Oct; 54():83-88. PubMed ID: 29753174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
    Dohmen K; Kawano A; Takahashi K; Shigematsu H; Tanaka H; Haruno M; Yanagita K; Ichiki Y; Mori T; Hayashida K; Shimoda S; Ishibashi H; Nomura H
    Hepatogastroenterology; 2013; 60(128):2034-8. PubMed ID: 24719946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
    Suruki R; Hayashi K; Kusumoto K; Uto H; Ido A; Tsubouchi H; Stuver SO
    Int J Cancer; 2006 Jul; 119(1):192-5. PubMed ID: 16432841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Fedirko V; Trichopolou A; Bamia C; Duarte-Salles T; Trepo E; Aleksandrova K; Nöthlings U; Lukanova A; Lagiou P; Boffetta P; Trichopoulos D; Katzke VA; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Fagherazzi G; Bastide N; Panico S; Grioni S; Vineis P; Palli D; Tumino R; Bueno-de-Mesquita HB; Peeters PH; Skeie G; Engeset D; Parr CL; Jakszyn P; Sánchez MJ; Barricarte A; Amiano P; Chirlaque M; Quirós JR; Sund M; Werner M; Sonestedt E; Ericson U; Key TJ; Khaw KT; Ferrari P; Romieu I; Riboli E; Jenab M
    Ann Oncol; 2013 Aug; 24(8):2166-73. PubMed ID: 23670094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.